Immunotherapy protocol of culturing leukocytes in the presence o

Details Immunotherapy protocol of culturing leukocytes in the presence o Immunotherapy protocol of culturing leukocytes in the presence o

1995-06-07

1997-05-20

Feisee, Lila

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Animal or plant cell

424520, 435400, A61K 3512, A61K 3514, A61K 3526, C12N 508

Patent

active

056310064

ABSTRACT:
An immunotherapy protocol in which leukocytes are cultured in the presence of interleukin-2 in a hollow fiber cartridge perfusion system for at least four days to achieve a harvest yield of at least 100% of leukocytes with respect to the number of cells initially present in the hollow cartridge, and where the leukocytes have a lytic activity at least equal to that of cells grown in a static culturing system and where the lytic activity of the cells following the culture period in the hollow fiber is at least equal to cells grown in a static culturing system.

REFERENCES:
patent: 4364932 (1982-12-01), Kung et al.
patent: 4391912 (1983-07-01), Yoshida et al.
patent: 4401756 (1983-08-01), Gillis
patent: 4404280 (1983-09-01), Gillis
patent: 4407945 (1983-10-01), Gillis
patent: 4438032 (1984-03-01), Golde et al.
patent: 4444887 (1984-04-01), Hoffmann
patent: 4464355 (1984-08-01), Fabricius et al.
patent: 4473642 (1984-09-01), Gillis
patent: 4490289 (1984-12-01), Stern
patent: 4515893 (1985-05-01), Kung et al.
patent: 4515894 (1985-05-01), Kung et al.
patent: 4515895 (1985-05-01), Kung et al.
patent: 4544632 (1985-10-01), Yamamura et al.
patent: 4690915 (1987-09-01), Rosenberg
patent: 4804628 (1989-02-01), Cracauer et al.
Hopkinson Biotechnology 3:226-230 (1985).
Abersold et al. INCI 83:932-937 (1991).
Rosenberg et al. INCI 86:1159-1166 (1994).
Mule et al., Science 225, pp. 1487-1489 (1984).
Lotze, M.T., Transplantation and Adoptive Cellular Therapy of Cancer; The Role of T Cell Growth Factors, Cell Trans. vol. 2:33-47, 1993.
Lindemann et al., Lymphokine Activated Killer Cells. Blut vol. 59:375-384, 1989.
Stites et al. (ed.) Basic & Clinical Immunology. 5th Ed., Laner Medical Publications, Los Angeles, CA pp. 92-96, 1984.
Teichmann et al., Susceptibility of Human Leukemia to Allogeneic and Autologous Lymphokine-activated Killer Cell Activity: Analysis of 252 Samples. Nat. Immun. vol. 11:117-132. 1992.
Nabel et al., Cell 23 pp. 19-28 (1981).

Affiliated with

Also associated with

Rating

Immunotherapy protocol of culturing leukocytes in the presence o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapy protocol of culturing leukocytes in the presence o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapy protocol of culturing leukocytes in the presence o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1722127